Medtronic Future Growth
Future criteria checks 0/6
Medtronic is forecast to grow earnings and revenue by 10.1% and 4.6% per annum respectively. EPS is expected to grow by 10.7% per annum. Return on equity is forecast to be 15.2% in 3 years.
Key information
10.1%
Earnings growth rate
10.7%
EPS growth rate
| Medical Equipment earnings growth | 18.3% |
| Revenue growth rate | 4.6% |
| Future return on equity | 15.2% |
| Analyst coverage | Good |
| Last updated | 23 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 4/30/2027 | 36,904 | 6,200 | 7,639 | 9,294 | 25 |
| 4/30/2026 | 35,126 | 5,733 | 6,857 | 8,710 | 32 |
| 4/30/2025 | 33,560 | 5,274 | 6,018 | 7,924 | 31 |
| 10/25/2024 | 32,996 | 4,288 | 5,499 | 7,195 | N/A |
| 7/26/2024 | 32,577 | 3,927 | 5,145 | 6,898 | N/A |
| 4/26/2024 | 32,364 | 3,676 | 5,200 | 6,787 | N/A |
| 1/26/2024 | 32,320 | 4,201 | 4,931 | 6,470 | N/A |
| 10/27/2023 | 31,958 | 4,102 | 4,045 | 5,570 | N/A |
| 7/28/2023 | 31,558 | 3,620 | 4,444 | 5,831 | N/A |
| 4/28/2023 | 31,227 | 3,758 | 4,580 | 6,039 | N/A |
| 1/27/2023 | 30,771 | 4,064 | 4,166 | 5,636 | N/A |
| 10/28/2022 | 30,806 | 4,321 | 4,822 | 6,290 | N/A |
| 7/29/2022 | 31,070 | 5,205 | 5,721 | 7,137 | N/A |
| 4/29/2022 | 31,686 | 5,039 | 5,978 | 7,346 | N/A |
| 1/28/2022 | 31,785 | 4,914 | 5,678 | 7,034 | N/A |
| 10/29/2021 | 31,798 | 4,704 | 5,773 | 7,162 | N/A |
| 7/30/2021 | 31,597 | 3,882 | 5,855 | 7,254 | N/A |
| 4/30/2021 | 30,117 | 3,606 | 4,885 | 6,240 | N/A |
| 1/29/2021 | 27,926 | 2,892 | 4,631 | 5,945 | N/A |
| 10/30/2020 | 27,868 | 3,537 | 4,752 | 5,996 | N/A |
| 7/31/2020 | 27,927 | 4,412 | 4,756 | 6,002 | N/A |
| 4/24/2020 | 28,913 | 4,789 | 6,021 | 7,234 | N/A |
| 1/24/2020 | 31,062 | 5,408 | 6,659 | 7,871 | N/A |
| 10/25/2019 | 30,891 | 4,762 | 6,298 | 7,519 | N/A |
| 7/26/2019 | 30,666 | 4,420 | 5,671 | 6,815 | N/A |
| 4/26/2019 | 30,557 | 4,631 | 5,873 | 7,007 | N/A |
| 1/25/2019 | 30,555 | 4,826 | 4,867 | 5,958 | N/A |
| 10/26/2018 | 30,378 | 2,168 | 4,864 | 5,905 | N/A |
| 7/27/2018 | 29,947 | 3,163 | N/A | 5,649 | N/A |
| 4/27/2018 | 29,953 | 3,104 | N/A | 4,684 | N/A |
| 1/26/2018 | 29,725 | 2,859 | N/A | 5,419 | N/A |
| 10/27/2017 | 29,639 | 5,069 | N/A | 5,502 | N/A |
| 7/28/2017 | 29,934 | 4,115 | N/A | 6,067 | N/A |
| 4/28/2017 | 29,710 | 4,028 | N/A | 6,880 | N/A |
| 1/27/2017 | 29,361 | 3,968 | N/A | 6,433 | N/A |
| 10/28/2016 | 29,012 | 4,242 | N/A | 6,145 | N/A |
| 7/29/2016 | 28,725 | 3,647 | N/A | 5,952 | N/A |
| 4/29/2016 | 28,833 | 3,538 | N/A | 5,218 | N/A |
| 1/29/2016 | 28,435 | 2,434 | N/A | 5,804 | N/A |
| 10/30/2015 | 25,819 | 2,316 | N/A | 5,774 | N/A |
| 7/31/2015 | 23,127 | 2,624 | N/A | 5,408 | N/A |
| 4/24/2015 | 20,261 | 2,675 | N/A | 4,902 | N/A |
| 1/23/2015 | 17,410 | 3,124 | N/A | 4,318 | N/A |
| 10/24/2014 | 17,255 | 2,909 | N/A | 4,163 | N/A |
| 7/25/2014 | 17,083 | 2,983 | N/A | 4,286 | N/A |
| 4/25/2014 | 16,893 | 3,065 | N/A | 4,959 | N/A |
| 1/24/2014 | 16,879 | 3,586 | N/A | 4,901 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MDTC34's forecast earnings growth (10.1% per year) is below the savings rate (10.4%).
Earnings vs Market: MDTC34's earnings (10.1% per year) are forecast to grow slower than the BR market (12.6% per year).
High Growth Earnings: MDTC34's earnings are forecast to grow, but not significantly.
Revenue vs Market: MDTC34's revenue (4.6% per year) is forecast to grow slower than the BR market (7.4% per year).
High Growth Revenue: MDTC34's revenue (4.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MDTC34's Return on Equity is forecast to be low in 3 years time (15.2%).